What is AlloSource?
Founded in 1994 and based in Colorado, AlloSource operates as a nonprofit entity focused on the advancement of allogeneic cell and tissue transplantation. The organization's mission is to provide surgeons with essential materials to heal patients, thereby contributing to medical innovation and patient care. AlloSource's work is pivotal in bridging the gap between scientific research and practical clinical application in regenerative medicine and tissue engineering.
How much funding has AlloSource raised?
AlloSource has raised a total of $5M across 1 funding round:
Debt
$5M
Debt (2020): $5M with participation from PPP
What's next for AlloSource?
The recent major strategic investment positions AlloSource for significant growth and expansion in its mission-critical activities. This influx of capital is expected to fuel further research and development in allogeneic cell and tissue therapies, potentially leading to new treatment modalities and improved patient outcomes. The enterprise-level backing suggests a strategic focus on scaling operations and enhancing its impact within the healthcare sector, solidifying its position as a leader in the field of tissue and cell science.
See full AlloSource company page